FIBROGEN INC — Director's Dealing 2016

Feb 10, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2016-02-05

Reporting Person: Cotroneo Pat (VP, Finance and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-02-05	Common Stock	M	3627	$2.90	Acquired	114952	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-02-05	Stock Option (Right to Buy)	$2.90	M	3100	Disposed	2020-06-24	Common Stock (3100)	Direct
2016-02-05	Stock Option (Right to Buy)	$2.90	M	527	Disposed	2020-06-24	Common Stock (527)	Direct

Footnotes

F1: Fully vested.